Validating Different Liver 3D Tissue Models to Advance Therapeutic Screening
Time: 9:30 am
day: Day 1
Details:
- Addressing the importance of implementing human specific models to empower better target validation and therapeutic screening
- Utilizing spheroids and MPS as replacements for animal research or to reduce animal use
- Discussing the optimization of 3D cell systems to enhance their utility in drug discovery, ensuring relevance, reliability, and replicability in metabolic disease research
